The Duke Cancer Network has expertise in building value-based programs that define best practices and enhance quality to best serve the needs of your community.

United States
Joined July 2016
Pearl from Dr Galanos: “Palliative care is not: hospice, end of life care only, or the abdication of pt. It is not an either/or. You can have tx AND palliative care” #DCN2019 – at Cary, NC
1
8
20
#DCR2019 is off and running! Follow us to learn about the latest advances in cancer care. @DukeMedSchool @DukePallCare @PDCDuke @DukeCancer – at Cary, NC
2
8
A packed room of Advanced Practice Providers getting special attention at a focused seminar at #DUKEhemeDebates
2
Dr. Strickler @ #DukeGIDebates argues Phase III data not available, but studies suggest Total Neoadjuvant Therapy is at least not inferior to ‘sandwich’ therapy for rectal cancer. Notes improved pt tolerance & incorporation of TNT into NCCN 2019 guidelines as standard of care
1
2
6
Czito debating the benefit of Total Neoadj Therapy for rectal cancer for #DukeGIDebates acknowledges that increasing cycles of mFOLFOX6 after Chemotherapy/EBRT and before Surgery for rectal ca: increases Path CR rates and response without tumor progression, BUT....
2
Seating is limited. Please register early goo.gl/YWybnn
Day Two has begun! Follow our live tweets with #DukeCancerReview
4
Friday session has begun! #DukeCancerReview – at Cary, NC
5
#DUKEhemeDEBATES DrMichelKhouri@Duke urges prevention, early detection/treatment of cardiac toxicity/disease in pts with cancer. Accelerated CV aging seen in pts with cancer and cancerRx may be due to proinflam mediators in both CVD/Ca.
1
1
2
#DUKEhemeDEBATES Dr. Lindsay Rein asks “Should we rock the boat with improved survival from TKIs in CML?" Notes negative health impact in younger pts; #financialtox overall; cautions not yet enough data to stop TKIs as SOC #ImatinibWithdrlSyndrom (?other TKIs) needs more research
1
1
1